Trial Profile
Effects of atorvastatin on leukotriene B4 levels and LDL cholesterol particle size in coronary artery disease patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Apr 2012
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary)
- Indications Coronary artery disease
- Focus Pharmacodynamics
- 29 Mar 2012 Results assessing the effects of treatment on low-density lipoprotein cholesterol particle sizes presented at the 16th International Symposium on Atherosclerosis.
- 29 Mar 2012 Results assessing the effects of treatment on leukotriene B4 levels presented at the 16th International Symposium on Atherosclerosis.
- 05 Nov 2010 New trial record.